Annual Operating Expenses
$27.00 M
-$9.30 M-25.63%
01 July 2024
Summary:
Enzo Biochem annual total operating expenses is currently $27.00 million, with the most recent change of -$9.30 million (-25.63%) on 01 July 2024. During the last 3 years, it has fallen by -$25.89 million (-48.95%). ENZ annual operating expenses is now -59.72% below its all-time high of $67.02 million, reached on 31 July 2010.ENZ Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$8.41 M
+$3.33 M+65.46%
01 July 2024
Summary:
Enzo Biochem quarterly total operating expenses is currently $8.41 million, with the most recent change of +$3.33 million (+65.46%) on 01 July 2024. Over the past year, it has increased by +$556.00 thousand (+7.08%). ENZ quarterly operating expenses is now -57.53% below its all-time high of $19.81 million, reached on 31 July 2010.ENZ Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENZ Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.6% | +7.1% |
| 3 y3 years | -49.0% | -28.7% |
| 5 y5 years | -43.1% | -31.0% |
ENZ Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -49.0% | +5.8% | -49.1% | +159.5% |
| 5 y | 5 years | -50.1% | +5.8% | -53.2% | +159.5% |
| alltime | all time | -59.7% | +2149.8% | -57.5% | +159.5% |
Enzo Biochem Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | $27.00 M(-25.6%) | $8.41 M(+65.5%) |
| Apr 2024 | - | $5.08 M(-10.0%) |
| Jan 2024 | - | $5.65 M(-28.1%) |
| Oct 2023 | - | $7.86 M(-52.4%) |
| July 2023 | $36.30 M(+42.2%) | $16.52 M(+132.8%) |
| Apr 2023 | - | $7.10 M(+8.3%) |
| Jan 2023 | - | $6.55 M(+6.8%) |
| Oct 2022 | - | $6.14 M(-143.4%) |
| July 2022 | $25.52 M(-51.7%) | -$14.13 M(-212.4%) |
| Apr 2022 | - | $12.57 M(-17.7%) |
| Jan 2022 | - | $15.29 M(+29.6%) |
| Oct 2021 | - | $11.80 M(-32.2%) |
| July 2021 | $52.88 M(-2.3%) | $17.39 M(+34.6%) |
| Apr 2021 | - | $12.92 M(+9.3%) |
| Jan 2021 | - | $11.82 M(+9.8%) |
| Oct 2020 | - | $10.76 M(-40.1%) |
| July 2020 | $54.14 M(+14.1%) | $17.96 M(+46.9%) |
| Apr 2020 | - | $12.22 M(+4.0%) |
| Jan 2020 | - | $11.76 M(-3.6%) |
| Oct 2019 | - | $12.19 M(+4.1%) |
| July 2019 | $47.44 M(-0.5%) | $11.71 M(+0.1%) |
| Apr 2019 | - | $11.70 M(-5.1%) |
| Jan 2019 | - | $12.33 M(+5.4%) |
| Oct 2018 | - | $11.70 M(-5.1%) |
| July 2018 | $47.66 M(+1.2%) | $12.33 M(+4.3%) |
| Apr 2018 | - | $11.82 M(-0.3%) |
| Jan 2018 | - | $11.86 M(+1.8%) |
| Oct 2017 | - | $11.65 M(+19.0%) |
| July 2017 | $47.08 M(-5.1%) | $9.79 M(-17.9%) |
| Apr 2017 | - | $11.92 M(-3.7%) |
| Jan 2017 | - | $12.38 M(-4.7%) |
| Oct 2016 | - | $12.98 M(+0.8%) |
| July 2016 | $49.60 M(+6.2%) | $12.88 M(+4.5%) |
| Apr 2016 | - | $12.33 M(-2.2%) |
| Jan 2016 | - | $12.60 M(+6.8%) |
| Oct 2015 | - | $11.80 M(-5.2%) |
| July 2015 | $46.70 M(-2.7%) | $12.44 M(+7.7%) |
| Apr 2015 | - | $11.54 M(+4.0%) |
| Jan 2015 | - | $11.11 M(-4.4%) |
| Oct 2014 | - | $11.62 M(-1.7%) |
| July 2014 | $48.01 M(-7.8%) | $11.82 M(-2.6%) |
| Apr 2014 | - | $12.14 M(+2.6%) |
| Jan 2014 | - | $11.83 M(-3.2%) |
| Oct 2013 | - | $12.22 M(+2.9%) |
| July 2013 | $52.04 M(-12.3%) | $11.87 M(-8.3%) |
| Apr 2013 | - | $12.95 M(-1.9%) |
| Jan 2013 | - | $13.20 M(-5.9%) |
| Oct 2012 | - | $14.02 M(-6.7%) |
| July 2012 | $59.33 M(+3.3%) | $15.03 M(+2.7%) |
| Apr 2012 | - | $14.63 M(+1.9%) |
| Jan 2012 | - | $14.36 M(-11.2%) |
| Oct 2011 | - | $16.16 M(+31.0%) |
| July 2011 | $57.43 M(-14.3%) | $12.34 M(-15.6%) |
| Apr 2011 | - | $14.63 M(-8.0%) |
| Jan 2011 | - | $15.89 M(+9.2%) |
| Oct 2010 | - | $14.56 M(-26.5%) |
| July 2010 | $67.02 M(+20.3%) | $19.81 M(+33.9%) |
| Apr 2010 | - | $14.80 M(-14.1%) |
| Jan 2010 | - | $17.23 M(+13.4%) |
| Oct 2009 | - | $15.19 M(-2.0%) |
| July 2009 | $55.72 M(+6.4%) | $15.50 M(+17.7%) |
| Apr 2009 | - | $13.17 M(-7.1%) |
| Jan 2009 | - | $14.18 M(-3.2%) |
| Oct 2008 | - | $14.65 M(+9.7%) |
| July 2008 | $52.36 M(+3.4%) | $13.35 M(+10.8%) |
| Apr 2008 | - | $12.05 M(-15.4%) |
| Jan 2008 | - | $14.24 M(+12.0%) |
| Oct 2007 | - | $12.71 M(-9.8%) |
| July 2007 | $50.64 M(+16.0%) | $14.10 M(+6.5%) |
| Apr 2007 | - | $13.24 M(+3.7%) |
| Jan 2007 | - | $12.76 M(+22.1%) |
| Oct 2006 | - | $10.45 M(-7.4%) |
| July 2006 | $43.66 M | $11.28 M(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2006 | - | $10.29 M(-14.8%) |
| Jan 2006 | - | $12.08 M(+20.6%) |
| Oct 2005 | - | $10.01 M(-6.3%) |
| July 2005 | $38.73 M(-5.0%) | $10.69 M(+6.8%) |
| Apr 2005 | - | $10.00 M(+10.2%) |
| Jan 2005 | - | $9.07 M(+1.2%) |
| Oct 2004 | - | $8.97 M(-18.7%) |
| July 2004 | $40.77 M(+11.4%) | $11.04 M(+11.5%) |
| Apr 2004 | - | $9.90 M(-11.3%) |
| Jan 2004 | - | $11.16 M(+30.5%) |
| Oct 2003 | - | $8.55 M(-32.5%) |
| July 2003 | $36.61 M(+7.1%) | $12.67 M(+73.7%) |
| Apr 2003 | - | $7.30 M(-13.5%) |
| Jan 2003 | - | $8.44 M(+2.9%) |
| Oct 2002 | - | $8.20 M(-15.1%) |
| July 2002 | $34.18 M(+7.6%) | $9.66 M(+12.6%) |
| Apr 2002 | - | $8.58 M(+7.4%) |
| Jan 2002 | - | $7.99 M(+1.1%) |
| Oct 2001 | - | $7.90 M(+1.5%) |
| July 2001 | $31.75 M(+3.0%) | $7.78 M(-5.8%) |
| Apr 2001 | - | $8.27 M(-2.3%) |
| Jan 2001 | - | $8.46 M(+1.6%) |
| Oct 2000 | - | $8.33 M(-4.2%) |
| July 2000 | $30.84 M(+15.5%) | $8.69 M(+13.0%) |
| Apr 2000 | - | $7.69 M(+4.0%) |
| Jan 2000 | - | $7.40 M(+4.2%) |
| Oct 1999 | - | $7.10 M(+14.5%) |
| July 1999 | $26.70 M(+3.5%) | $6.20 M(-10.1%) |
| Apr 1999 | - | $6.90 M(-1.4%) |
| Jan 1999 | - | $7.00 M(+6.1%) |
| Oct 1998 | - | $6.60 M(+4.8%) |
| July 1998 | $25.80 M(+20.6%) | $6.30 M(-8.7%) |
| Apr 1998 | - | $6.90 M(+6.2%) |
| Jan 1998 | - | $6.50 M(+6.6%) |
| Oct 1997 | - | $6.10 M(-4.7%) |
| July 1997 | $21.40 M(-4.5%) | $6.40 M(+25.5%) |
| Apr 1997 | - | $5.10 M(+6.3%) |
| Jan 1997 | - | $4.80 M(-2.0%) |
| Oct 1996 | - | $4.90 M(-55.0%) |
| July 1996 | $22.40 M(+5.2%) | $10.90 M(+186.8%) |
| Apr 1996 | - | $3.80 M(-19.1%) |
| Jan 1996 | - | $4.70 M(+9.3%) |
| Oct 1995 | - | $4.30 M(-47.6%) |
| July 1995 | $21.30 M(+53.2%) | $8.20 M(+64.0%) |
| Apr 1995 | - | $5.00 M(+51.5%) |
| Jan 1995 | - | $3.30 M(-19.5%) |
| Oct 1994 | - | $4.10 M(+2.5%) |
| July 1994 | $13.90 M(-24.5%) | $4.00 M(+14.3%) |
| Apr 1994 | - | $3.50 M(0.0%) |
| Jan 1994 | - | $3.50 M(+12.9%) |
| Oct 1993 | - | $3.10 M(-62.7%) |
| July 1993 | $18.40 M(+35.3%) | $8.30 M(+151.5%) |
| Apr 1993 | - | $3.30 M(0.0%) |
| Jan 1993 | - | $3.30 M(-5.7%) |
| Oct 1992 | - | $3.50 M(+6.1%) |
| July 1992 | $13.60 M(+1033.3%) | $3.30 M(-10.8%) |
| Apr 1992 | - | $3.70 M(+23.3%) |
| Jan 1992 | - | $3.00 M(-14.3%) |
| Oct 1991 | - | $3.50 M(-128.5%) |
| July 1991 | $1.20 M(-92.6%) | -$12.30 M(-367.4%) |
| Apr 1991 | - | $4.60 M(0.0%) |
| Jan 1991 | - | $4.60 M(+4.5%) |
| Oct 1990 | - | $4.40 M(+51.7%) |
| July 1990 | $16.30 M(+30.4%) | $2.90 M(-39.6%) |
| Apr 1990 | - | $4.80 M(+2.1%) |
| Jan 1990 | - | $4.70 M(+20.5%) |
| Oct 1989 | - | $3.90 M |
| July 1989 | $12.50 M(+23.8%) | - |
| July 1988 | $10.10 M(0.0%) | - |
| July 1987 | $10.10 M(+110.4%) | - |
| July 1986 | $4.80 M(+29.7%) | - |
| July 1985 | $3.70 M(+32.1%) | - |
| July 1984 | $2.80 M | - |
FAQ
- What is Enzo Biochem annual total operating expenses?
- What is the all time high annual operating expenses for Enzo Biochem?
- What is Enzo Biochem annual operating expenses year-on-year change?
- What is Enzo Biochem quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Enzo Biochem?
- What is Enzo Biochem quarterly operating expenses year-on-year change?
What is Enzo Biochem annual total operating expenses?
The current annual operating expenses of ENZ is $27.00 M
What is the all time high annual operating expenses for Enzo Biochem?
Enzo Biochem all-time high annual total operating expenses is $67.02 M
What is Enzo Biochem annual operating expenses year-on-year change?
Over the past year, ENZ annual total operating expenses has changed by -$9.30 M (-25.63%)
What is Enzo Biochem quarterly total operating expenses?
The current quarterly operating expenses of ENZ is $8.41 M
What is the all time high quarterly operating expenses for Enzo Biochem?
Enzo Biochem all-time high quarterly total operating expenses is $19.81 M
What is Enzo Biochem quarterly operating expenses year-on-year change?
Over the past year, ENZ quarterly total operating expenses has changed by +$556.00 K (+7.08%)